Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Medical Countermeasures

    Operation Warp Speed’s Big Vaccine Contracts Could Stay Secret

    By Global Biodefense StaffSeptember 29, 2020
    Credit: Global Biodefense
    Share
    Facebook LinkedIn Reddit Email

    Instead of entering into contracts directly with vaccine makers, more than $6 billion in Operation Warp Speed funding has been routed through a defense contract management firm called Advanced Technologies International, Inc. ATI then awarded contracts to companies working on COVID-19 vaccines.

    As a result, the contracts between the pharmaceutical companies and ATI may not be available through public records requests, and additional documents are exempt from public disclosure for five years.

    Vaccine contracts awarded this way include $1.6 billion for Novavax, $1.95 billion for Pfizer, $1.79 billion for Sanofi and $1 billion for Johnson & Johnson.

    NPR first began looking into the possibility of a third party when HHS responded that it had “no records” in response to a federal Freedom of Information Act request for the $1.6 billion vaccine contract with Novavax, which the agency announced in July.

    Read more by Sydney Lupkin at NPR

    Trump administration’s project to develop a Covid-19 vaccine – which is funneling money through a nongovernmental intermediary, a move that is likely to reignite worries over the project’s opaque nature.

    Operation Warp Speed’s opaque choices of COVID-19 vaccines draw Senate scrutiny

    At Senate subcommittee hearing on 2 July 2020 that focused on Warp Speed, scientists at the front of the effort, after repeated questioning, gave limited answers about the vaccine candidates they have chosen for funding and their selection criteria.

    At the opening of the hearing—held by the Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies—Senator Patty Murray (D–WA) put the witnesses on notice that she wanted straightforward answers on many issues. “We’re going to need to hold this administration accountable to avoid repeating mistakes and delays,” Murray said. “The administration still has not provided any explanation of how it is selecting vaccine candidates, what the risks are of narrowing down that shortlist or addressed concerns about potential conflicts in contracts that predate this crisis.”

    Read more by Jon Cohen at Science

    COVID Countermeasures COVID-19 Editor Pick SARS-CoV-2 Vaccine News
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleBasilea Awarded Additional Funding from U.S. Medical Countermeasure Program for Ceftobiprole Development
    Next Article Where in the World Will the Next Epidemic Start?

    Related Stories

    Biodefense Headlines – 30 November 2023

    November 30, 2023

    Virginia Tech Lab Selected for National Partnership to Fight Emerging Diseases

    November 14, 2023

    NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox

    November 14, 2023

    COVID Moonshot Consortium Announces Crowd-Sourced Small Molecule Discovery

    November 11, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Mar 12
    Hybrid Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.